ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627168; 2) Community: the network communities that were significantly associated with the response to NSC 627168; 3) Molecule: the relationships between components within communities and NSC 627168; 4) MDR: the compounds that were significantly associated with the NSC 627168.

NSC Compound Enrichment Correlation
NSC 645998 Null 0.0376362543535811 0.36535281
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0376362543535811 0.43408094
NSC 68093 Null 0.0376362543535811 0.37830902
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.0376362543535811 0.07226009
NSC 686553 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 0.0376362543535811 0.23493331
NSC 699092 Null 0.0376362543535811 0.069538057
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.0376362543535811 0.40355672
NSC 700582 [1,2,3,4]tetrathiocino[5,6-d:7,8-d']diimidazole -2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0376362543535812 0.15208608
NSC 742253 8-(4-Amino-1-methylbutyl)-amino-4-methyl-5,6-dimethoxyquinoline, diphosphate, 0.0376362543535812 0.057317589
NSC 174121 Methotrexate Derivative 0.0376362543535815 0.4202012
Total:81  Current:64    [First] [Prev] [Next] [Last]